Role of micronutrients and natural antioxidants in fighting against HIV; a quick mini-review

Document Type: Review


1 Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614411, Iran. Division of Pharmacy, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada.

2 Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, Iran.


Oxidative stress has been implicated in the progression of HIV to AIDS, since HIV usually replicates in a highly oxidized condition and CD4+ T lymphocytes can be activated via a cascade of internal oxidative pathways, which enhances the formation of proteins and enzymes. Thus, antioxidants should potentially be useful for the treatment and prevention of HIV infection as a new alternative strategy. Regarding the point that there are various approaches for treating the HIV-positive patients, antioxidant supplementation therapy alongside with other medications possesses many benefits. In fact, antioxidants and micronutrient supplements have been considered as a costly and short-term strategy to improve antioxidant deficiency. If diets come with sufficient education and scientific recommendations, they can provide a low-cost and long-term strategy to reduce oxidative stress, prevent micronutrient deficiency, and slow down HIV progression. This strategy may be applicable and beneficial particularly in countries around coast of Africa, where HIV is most common. Meantime these countries are rich of natural food resources. It seems that a healthy diet is the best way to insure proper nutrient intake, since it contains many nutrients not available in pills.


[1]  Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med. 2009; 60: 471-484.

[2]  Aquaro S, Scopelliti F, Pollicita M, Disclosures CFP. Oxidative stress and HIV infection: target pathways for novel therapies? Future HIV Ther. 2008; 2: 327-338.

[3]  AIDS epidemic update (2007). Last access date Aug 13, 2014. available from:

[4]  Saeidnia S, Abdollahi M. Toxicological and pharmacological concerns on oxidativestress and related diseases. Toxicol Appl Pharmacol. 2013; 273: 442-455.

[5]  Lopez O, Bonnefont-Rousselot D, Edeas M, Emerit J, Bricaire F. Could antioxidant suplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia? Biomed Pharmacother. 2003; 57: 113-116.

[6]  Madeddu G, Spanu A, Solinas P. Bone mass loss and vitamin D metabolism impairment in HIV-patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Im. 2004; 48: 39-48.

[7]  Nkengfack GN, Torimiro JN, Englert H. Effects of antioxidants on CD4 and viral load in HIV-infected women in sub-Saharan Africa - dietary supplements vs. local diet. Int J Vitam Nutr Res. 2012; 82: 63-72.

[8]  Botha C, Harman C, Spencer DC. Nutrition and HIV/AIDS: nutritional guidelines for HIV-infected adults and children in Southern Africa: meeting the needs (Sections 3-6).  South Afr J HIV Med. 2008; 29: 34.

[9]  Villamor E, Saathoff E, Bosch RJ,Hertzmark E, Baylin A, Manji K, Msamanga G, Hunter DJ, Fawzi WW. Vitamin supplementation of HIV-infected women improves postnatal child growth. Am J Clin Nutr. 2005; 81: 880-888.

[10]  Villamor E, Kapiga SH, Fawzi WW. Vitamin A serostatus and heterosexual transmission of HIV: case-control study in Tanzania and review of the evidence. Int J Vit Nutr Res. 2006; 76: 81-85.

[11]  van Lettow M, Harries AD, Kumwenda JJ,Zijlstra EE, Clark TD, Taha TE, Semba RD. Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect Dis. 2004; 4: 61.

[12]  Smith Fawzi MC, Kaaya SF, Mbwambo J, Msamanga GI, Antelman G, Wei R, Hunter DJ, Fawzi WW. Multivitamin supplementation in HIV-positive pregnant women: impact on depression and quality of life in a resource-poor setting. HIV Med. 2007; 8: 203-212.

[13]  Papathakis PC, Rollins NC, Chantry CJ, Bennish ML, Brown KH. Micronutrient status during lactation in HIV-infected and HIV-uninfected South African women during the first 6 mo after delivery.  Am J Clin Nutr. 2007; 85: 182-192.

[14]  Jiamto S, Chaisilwattana P, Pepin J, Suttent R, Mahakkanukrauh B, Filteau S, Suthipinittharm P, Jaffar S. A randomized placebo-controlled trial of the impact of multiple micronutrient supplementation on HIV-1 genital shedding among Thai subjects. J Acq  Immun Def Synd. 2004; 37: 1216-1218.

[15]  Austin J, Singhal N, Voigt  R, Smaill F, Gill MJ, Walmsley S, Salit I, Gilmour J, Schlech WF, Choudhri S, Rachlis A, Cohen J, Trottier S, Toma E, Phillips P, Ford PM, Woods R, Singer J, Zarowny DP, Cameron DW. A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. Eur J Clin Nutr. 2006; 60: 1266-1276.

[16]  Mohammadirad A, Khorram-Khorshid HR, Gharibdoost F, Abdollahi M. Setarud (IMODTM) as a multiherbal drug with promising benefits in animal and human studies: A comprehensive review of biochemical and cellular evidences. Asian J Anim Vet  Adv. 2011; 6: 1185-1192.

[17]  Agha-Hosseini F, Mirzaii-Dizgah I, Abdollahi M, Akbari-Gillani N. Efficacy of IMOD in the treatment of oral lichen planus. Open J Stomatology. 2011; 1: 13-17.

[18]  Saeidnia S, Abdollahi M.  Antioxidants; friends or foe in prevention or treatment of cancer; the debate of the century. Toxicol Appl Pharmacol. 2013; 271: 49-63.

[19]  Fassina G, Buffa A, Benelli R, Varnier OE, Noonan DM, Albini A. Polyphenolic antioxidant -epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS. 2002; 16: 939-941.

[20]  Bailly F, Cotelle P. Anti-HIV activities of natural antioxidant caffeic acid derivatives: toward an antiviral supplementation diet. Curr Med Chem. 2005; 12: 1811-1818.

[21]  Nair MP, Kandaswami C, Mahajan S, Nair HN, Chawda R, Shanahan T, Schwartz SA. Grape seed extract proanthocyanidins downregulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells. Biol Res. 2002; 35: 421-431.

[22]  Critchfield WJ, Butera ST, Folks TM. Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res Hum Retroviruses. 1996; 12: 39-46.